Quick Answer
Xenetic Biosciences, Inc. reported Total Assets of $8.36 million for the year ending 2025.
- Xenetic Biosciences, Inc. showed an increase of +21.2% in Total Assets from 2024 to 2025.
- This data is from Xenetic Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $251.0 thousand | Q2 2012: $303.9 thousand | Q4 2012: $351.8 thousand | Q1 2013: $270.7 thousand | Q2 2013: $277.4 thousand | Q3 2013: $486.8 thousand | Q4 2013: $449.0 thousand | Q1 2014: $25.87 million | Q2 2014: $23.05 million | Q3 2014: $19.32 million | Q1 2015: $14.04 million | Q2 2015: $13.27 million | Q3 2015: $14.25 million | Q1 2016: $18.36 million | Q2 2016: $13.16 million | Q3 2016: $13.87 million | Q1 2017: $18.83 million | Q2 2017: $16.44 million | Q3 2017: $14.64 million | Q1 2018: $17.54 million | Q2 2018: $17.26 million | Q3 2018: $15.53 million | Q1 2019: $16.46 million | Q2 2019: $15.63 million | Q3 2019: $22.88 million | Q1 2020: $20.63 million | Q2 2020: $19.06 million | Q3 2020: $8.70 million | Q1 2021: $11.76 million | Q2 2021: $10.92 million | Q3 2021: $21.29 million | Q1 2022: $17.98 million | Q2 2022: $16.47 million | Q3 2022: $15.57 million | Q1 2023: $13.72 million | Q2 2023: $12.75 million | Q3 2023: $11.96 million | Q1 2024: $9.39 million | Q2 2024: $9.03 million | Q3 2024: $8.05 million | Q1 2025: $5.79 million | Q2 2025: $5.35 million | Q3 2025: $5.07 million.
- Over the full 16 years of available data (2011 to 2025), Xenetic Biosciences, Inc.'s Total Assets has grown by 3,659.0%.
- Historical annual values: Fiscal year 2025: $8.36 million | Fiscal year 2024: $6.90 million | Fiscal year 2023: $10.61 million | Fiscal year 2022: $14.72 million | Fiscal year 2021: $19.82 million | Fiscal year 2020: $13.18 million | Fiscal year 2019: $21.55 million | Fiscal year 2018: $14.43 million | Fiscal year 2017: $19.16 million | Fiscal year 2016: $20.97 million | Fiscal year 2015: $16.91 million | Fiscal year 2014: $16.32 million | Fiscal year 2013: $19.47 million | Fiscal year 2013: $486.8 thousand | Fiscal year 2012: $324.1 thousand | Fiscal year 2011: $222.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: